(Natural News) British pharmaceutical company AstraZeneca has
commenced late-stage trials for its COVID-19 antibody drug. In�an
Oct. 9 statement, the company said that two tests for the AZD7442
long-acting antibody drug, involving 6,000 adult participants
worldwide, will look at the medication’s ability to prevent
COVID-19 symptoms. A subsequent trial to observe AZD7442’s use as
a…

Prepare Now Before its too Late
Discover where products are available & compare prices